Assuming the EU Digital Certificate is not extended (again) then the competitive advantage of being on the Common List disappears. What competitive advantages are left for an expensive, unproven test. We can't really say it's accurate if we can't show evidence (the type of evidence gathered through a large scale medical trial).
Ann: European RAT Clinical Trial Halted to Refocus Initiatives, page-159
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
